Pulmonary Embolism and Increased Levels of D-Dimer in Patients with Coronavirus Disease.
作者信息
Chan Kok Hoe, Slim Jihad, Shaaban Hamid S
出版信息
Emerg Infect Dis. 2020 Oct;26(10):2522-2533. doi: 10.3201/eid2610.202127. Epub 2020 Jul 2.
Abstract
摘要
相似文献
1
Pulmonary Embolism and Increased Levels of D-Dimer in Patients with Coronavirus Disease.冠状病毒病患者的肺栓塞与D-二聚体水平升高
Emerg Infect Dis. 2020 Oct;26(10):2522-2533. doi: 10.3201/eid2610.202127. Epub 2020 Jul 2.
2
Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness.凝血因子 XIII 在急性肺栓塞患者中的作用。因子 XIII 抗原水平与肺栓塞率、纤维蛋白原、D - 二聚体及血凝块硬度的相关性。
Thromb Haemost. 2003 Sep;90(3):434-8. doi: 10.1160/TH03-07-0031.
3
COVID-19 infection and risk stratification for pulmonary embolism: Identifying optimal D-dimer thresholds.
Thromb Res. 2024 Mar;235:8-10. doi: 10.1016/j.thromres.2024.01.005. Epub 2024 Jan 12.
4
5
Combined measurement of factor XIII and D-dimer is helpful for differential diagnosis in patients with suspected pulmonary embolism.联合检测凝血因子 XIII 和 D - 二聚体有助于疑似肺栓塞患者的鉴别诊断。
Clin Chem Lab Med. 2017 Oct 26;55(12):1948-1953. doi: 10.1515/cclm-2017-0072.
6
Case Report: Tocilizumab for the Treatment of SARS-CoV-2 Infection in a Patient With Aplastic Anemia.病例报告：托珠单抗治疗再生障碍性贫血合并新型冠状病毒肺炎感染1例
Front Oncol. 2020 Sep 18;10:562625. doi: 10.3389/fonc.2020.562625. eCollection 2020.
7
Pulmonary embolism in COVID-19: D-dimer threshold selection should not be based on maximising Youden's index.新型冠状病毒肺炎相关肺血栓栓塞症：D-二聚体截断值选择不应基于最大化约登指数。
Eur Respir J. 2021 Feb 4;57(2). doi: 10.1183/13993003.04279-2020. Print 2021 Feb.
8
Pulmonary Embolism in COVID-19 and the Unanswered Questions.COVID-19中的肺栓塞及未解之谜
J Med Cases. 2020 Jun;11(6):174-177. doi: 10.14740/jmc3488. Epub 2020 May 28.
9
Coupled D dimer and fibrinogen levels during thrombolytic therapy of venous thromboembolism.
Thromb Res. 1992 Feb 1;65(3):457-62. doi: 10.1016/0049-3848(92)90176-b.
10
D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry.D-二聚体水平与急性肺栓塞患者的死亡率相关：RIETE注册研究结果
Crit Care Med. 2007 Aug;35(8):1937-41. doi: 10.1097/01.CCM.0000277044.25556.93.
引用本文的文献
1
Cerebral venous sinus thrombosis related to SARS-CoV-2 infection in a pediatric patient: A case report.一名儿科患者中与SARS-CoV-2感染相关的脑静脉窦血栓形成：病例报告
Radiol Case Rep. 2023 Aug 2;18(10):3592-3597. doi: 10.1016/j.radcr.2023.07.060. eCollection 2023 Oct.
2
Predicting COVID-19 outcomes from clinical and laboratory parameters in an intensive care facility during the second wave of the pandemic in South Africa.在南非第二波疫情期间，根据重症监护病房的临床和实验室参数预测新冠肺炎的预后。
IJID Reg. 2022 Jun;3:242-247. doi: 10.1016/j.ijregi.2022.03.024. Epub 2022 Apr 1.
3
Tocilizumab for Severe and Critical COVID-19 Pneumonia in Queens, NYC.托珠单抗治疗纽约市皇后区的重症和危重症新冠病毒肺炎
Infect Dis Clin Pract (Baltim Md). 2021 Jul;29(4):e215-e220. doi: 10.1097/IPC.0000000000000988. Epub 2021 Jan 15.
4
Lesson by SARS-CoV-2 disease (COVID-19): whole-body CT angiography detection of "relevant" and "other/incidental" systemic vascular findings.SARS-CoV-2 疾病（COVID-19）的教训：全身 CT 血管造影术对“相关”和“其他/偶然”全身血管发现的检测。
Eur Radiol. 2021 Oct;31(10):7363-7370. doi: 10.1007/s00330-021-07904-y. Epub 2021 Apr 16.
5
Life and Limb: a Case of COVID-19-Associated Multisystem Thrombosis and Review of the Literature.生命与肢体：一例新冠肺炎相关多系统血栓形成病例及文献综述
J Gen Intern Med. 2021 Mar;36(3):802-806. doi: 10.1007/s11606-020-06496-5. Epub 2021 Jan 5.
6
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.SARS-CoV-2（COVID-19）感染早期门诊治疗的病理生理基础和原理。
Am J Med. 2021 Jan;134(1):16-22. doi: 10.1016/j.amjmed.2020.07.003. Epub 2020 Aug 7.
本文引用的文献
1
Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.新型冠状病毒病患者的肺栓塞与 d-二聚体水平升高。
Emerg Infect Dis. 2020 Aug;26(8):1941-1943. doi: 10.3201/eid2608.201477. Epub 2020 Apr 29.
2
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.严重 COVID-19 中的细胞因子释放综合征：白细胞介素-6 受体拮抗剂托珠单抗可能是降低死亡率的关键。
Int J Antimicrob Agents. 2020 May;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29.
3
Crucial Involvement of IL-6 in Thrombus Resolution in Mice via Macrophage Recruitment and the Induction of Proteolytic Enzymes.IL-6 在小鼠血栓溶解中的关键作用：通过巨噬细胞募集和诱导蛋白水解酶。
Front Immunol. 2020 Feb 7;10:3150. doi: 10.3389/fimmu.2019.03150. eCollection 2019.
4
IL (Interleukin)-6 Contributes to Deep Vein Thrombosis and Is Negatively Regulated by miR-338-5p.白细胞介素 6（IL-6）有助于深静脉血栓形成，并受 miR-338-5p 的负调控。
Arterioscler Thromb Vasc Biol. 2020 Feb;40(2):323-334. doi: 10.1161/ATVBAHA.119.313137. Epub 2019 Dec 19.
5
Tocilizumab-associated multifocal cerebral thrombotic microangiopathy.托珠单抗相关的多灶性脑血栓性微血管病。
Neurol Clin Pract. 2016 Jun;6(3):e24-e26. doi: 10.1212/CPJ.0000000000000220.
Zotero 插件